Toute l’ingéniosité et la vitalité d’Oncodesign Services via notre espace ressources
Toutes les ressources et actualités à portée de main
Le processus de découverte et de développement d’une molécule est complexe, long et couteux. Avant de prendre une décision sur l’offre qui répond au mieux à votre besoin, nous vous proposons des ressources scientifiques (posters, publications, webinaires) en ligne, nos dernières actualités (congrès, communiqués de presse) pour mieux nous connaitre et nous rencontrer. Nos experts sont également à votre disposition pour vous aider et vous accompagner dans votre programme de recherche et développement.
Filtrer par catégorie
- Tous
- Blog
- Congrès
- Ressource Scientifique
- Webinaire
- Poster
- Publication scientifique
- Communiqué de Presse
- Couverture presse
- Actualités
Filtrer par catégorie
Actualités
22/05/2023
Oncodesign Services and Veritas In Silico enter into business cooperation
Oncodesign Services and Veritas In Silico Inc. announced that they have entered into a Memorandum of Understanding to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA.
Blog
17/05/2023
Five Reasons why you should switch to digital PCR (dPCR)
Digital PCR has enhanced characteristics over qPCR across both its Protocols and Applications, including higher precision and sensitivity. Learn more here.
Webinaire
17/05/2023
[EN] Preclinical Models for the Identification of Chemotherapy Predictive Signatures in Pancreatic Cancer
Join the featured speakers to learn how they utilized preclinical models such as primary cell cultures, patient-derived xenografts, and patient-derived organoids to develop unbiased predictive RNA-based signatures.
Actualités
Ressource Scientifique
09/05/2023
Recent trends in drug discovery of covalent binders
Download the complete e-book on the role of boron and benzoxaboroles as reversible covalent binders to target the serine and threonine proteome.
Blog
09/05/2023
Covalent drugs and the potential of benzoxaboroles
Molecules based on boron and benzoxaboroles are exciting as reversible covalent binders to target the serine and threonine proteome. In this blog, Christophe Parsy provides an overview of their potential to overcome traditional limitations in kinase inhibition, highlighting the exciting possibilities for future Drug Discovery.
Ressource Scientifique
Congress
24/04/2023
Poster AACR Annual Meeting 2023
Discover our Posters presented in AACR Annual Meeting 2023!
Blog
12/04/2023
Challenges and perspectives in the preclinical development of therapeutic agents against lung fibrosis
Pulmonary fibrosis is estimated to affect more than 5 per 100,000 people per year in the USA and Europe, without known treatment to slow down, stop or even reverse the progression of the disease. In this blog, Pauline Bornert examines the current knowledge about pulmonary fibrosis, and preclinical options available to develop new therapeutic solutions.
Poster
03/04/2023
Preclinical evaluation of a chimpanzee adenovirus vector expressing a pre-fusion Spike (BV-AdCoV-1) SARS-CoV-2 intranasal vaccine candidate in golden Syrian hamsters
Download the e-poster and learn more about Chimpanzee Adenovirus vector SARS-CoV-2 intranasal Vaccine Candidate from Oncodesign Services.
Poster
28/03/2023
New target identification and validation platform combining AI in oncology and preclinical pharmacology
The OncoSNIPE® project combines Ai in Oncology and Preclinical Pharmacology to develop a new identification and validation platform. Learn more here
Poster
28/03/2023
DRIVE-Biologics: all the steps from discovery to development of novel biological therapeutics
DRIVE-Biologics aims to optimize your biologics therapeutics and drug discovery through stages of preclinical evaluation to clinical studies. Learn more here